Bessemer Group Inc. Acquires 32,228 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Bessemer Group Inc. raised its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,830,561 shares of the medical device company's stock after purchasing an additional 32,228 shares during the quarter. Bessemer Group Inc. owned 0.92% of Cooper Companies worth $154,408,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of COO. OFI Invest Asset Management acquired a new stake in Cooper Companies in the 4th quarter valued at approximately $34,000. City Holding Co. bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $38,000. Covestor Ltd lifted its position in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Atala Financial Inc bought a new stake in shares of Cooper Companies in the fourth quarter worth $51,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Up 0.2%

COO stock traded up $0.15 during mid-day trading on Thursday, reaching $69.69. The company's stock had a trading volume of 1,518,908 shares, compared to its average volume of 1,672,999. The company has a market cap of $13.94 billion, a price-to-earnings ratio of 33.83, a price-to-earnings-growth ratio of 1.70 and a beta of 0.98. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The business's 50 day moving average price is $76.78 and its 200 day moving average price is $84.53.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the business posted $0.85 EPS. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on COO. Wells Fargo & Company lowered their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Loop Capital set a $100.00 price objective on Cooper Companies in a report on Tuesday, June 17th. Citigroup dropped their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC raised Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target for the company in a research report on Tuesday, June 17th. Finally, Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and an average price target of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.